[HTML][HTML] The ameliorating effects of metformin on disarrangement ongoing in gastrocnemius muscle of sarcopenic and obese sarcopenic mice
Q Lyu, Y Wen, B He, X Zhang, J Chen, Y Sun… - … et Biophysica Acta (BBA …, 2022 - Elsevier
Sarcopenia and obese sarcopenia are increasingly prevalent chronic diseases with
multifactorial pathogenesis, and no approved therapeutic drug to date. In the established …
multifactorial pathogenesis, and no approved therapeutic drug to date. In the established …
The ameliorating effects of metformin on disarrangement ongoing in gastrocnemius muscle of sarcopenic and obese sarcopenic mice
Q Lyu, Y Wen, B He, X Zhang… - … et biophysica acta …, 2022 - pubmed.ncbi.nlm.nih.gov
Sarcopenia and obese sarcopenia are increasingly prevalent chronic diseases with
multifactorial pathogenesis, and no approved therapeutic drug to date. In the established …
multifactorial pathogenesis, and no approved therapeutic drug to date. In the established …
The ameliorating effects of metformin on disarrangement ongoing in gastrocnemius muscle of sarcopenic and obese sarcopenic mice.
Q Lyu, Y Wen, B He, X Zhang, J Chen… - … et Biophysica acta …, 2022 - europepmc.org
Sarcopenia and obese sarcopenia are increasingly prevalent chronic diseases with
multifactorial pathogenesis, and no approved therapeutic drug to date. In the established …
multifactorial pathogenesis, and no approved therapeutic drug to date. In the established …